Clinical Trials
592 trialsAdding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
SWOG Cancer Research Network
breast surgery
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
DOTA-STR-17126
Integrated Haematology and Oncology Network
A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants
Jiangsu HengRui Medicine Co., Ltd.
PCDM
University of Rochester
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
STREAK
University Hospital, Basel, Switzerland
preEMBER
Eli Lilly and Company
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
Genentech, Inc.
AROVAGUE
Institut Cancerologie de l'Ouest
ONSET
IRCCS San Raffaele
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer
Shanghai Henlius Biotech
Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial
Zhejiang Cancer Hospital
NEURO-BREAC-02
University Hospital Schleswig-Holstein
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep Learning
Yunnan Cancer Hospital
Real-Time IGRT
University of Sydney
PSID
Washington University School of Medicine
Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
Dana-Farber Cancer Institute
Cancer
Federal University of Maranhao
ADES
Peking University Cancer Hospital & Institute
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Peking University People's Hospital
Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors
University of Southern Queensland
Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients
Ohio State University Comprehensive Cancer Center
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
University of Illinois at Chicago
A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.
Overcoming Racial Disparities in Screening Mammography
Washington University School of Medicine
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
Peking University People's Hospital
DETE-BR
West China Hospital
GATHER
Centre Henri Becquerel
B-BIT
Seoul St. Mary's Hospital
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP
The First Affiliated Hospital with Nanjing Medical University
Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial
City of Hope Medical Center
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer
Akeso
Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
National Cancer Institute (NCI)
Effects of Moderate-intensity Interval Aerobic Exercise (MIIAE) on Inflammatory, Immune, Metabolic, Physical Fitness, and Quality of Life Parameters in Breast Cancer Patients Undergoing Radiotherapy.
Universidad Francisco de Vitoria
DETOXp
Montefiore Medical Center
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Canadian Cancer Trials Group
A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors
Health Hope Pharma
Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)
Telomir Pharmaceuticals, Inc.
SPECTACLE
Fudan University
APIS
Hospices Civils de Lyon
BREATH-RCT
Ondokuz Mayıs University
SPSIP-RIB
Antalya City Hospital
SDM-01
Federico II University
EVA
European Institute of Oncology
The Effect of Video-Assisted Mindfulness-Based Breathing on Quality of Life and Mental Well-Being in Individuals With Breast Cancer
Ege University
Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients
Washington University School of Medicine